Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)

NCT00365859 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
330
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators